GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed Jun 1, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-06-01$2.60/sh−78,938$205,239→ 10,786,413 total - Sale
Common Stock
2018-05-30$2.55/sh−100,000$255,000→ 10,865,351 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was made for estate planning purposes.